Centrus Q1 Revenue at $76.7M, Below Consensus
Reports Q1 revenue $76.7M, consensus $78.33M. The Company's backlog across both segments is $3.9B as of March 31 and extends to 2040. "The Q1 was marked by numerous wins and great operational progress as we accelerated our drive to restore America's ability to enrich uranium at scale, including securing historic federal funding and launching a major expansion of our centrifuge manufacturing plant," said Centrus President and CEO Amir Vexler. "We have now switched to full execution mode to accelerate our build-out while building a best-in-class partnership network, including Palantir, Fluor, and Geiger Brothers, as part of our day-one focus to reduce costs and bring in lead times. We've already identified approximately $300M in cost reductions as well as opportunities to both reduce manufacturing lead times and accelerate our timetable. Going forward we will continue to unleash our network's full capabilities, including Palantir's leading artificial intelligence platform, to unlock more efficiency gains."
